Position in ABVX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,215,280
+$3,258,339 QoQ
Shares Held
31,632
+268.1% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#116
of 302 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Derivatives in ABVX
reported options exposure · as of Jun 30, 2026CallValue
$1,732,380
CallShares
13,000
PutValue
$866,190
PutShares
6,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. ABVX ranks #27 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in ABVX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,215,280 | 31,632 | Shares | Sole | 2026-08-03 | |
| 2026-06-30 | $866,190 | 6,500 | Put | Sole | 2026-08-03 | |
| 2026-06-30 | $1,732,380 | 13,000 | Call | Sole | 2026-08-03 | |
| 2026-03-31 | $2,015,435 | 18,100 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $956,941 | 8,594 | Shares | Sole | 2026-05-13 | |
| 2026-03-31 | $534,480 | 4,800 | Put | Sole | 2026-05-13 | |
| 2025-12-31 | $310,166 | 2,300 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $3,116,364 | 23,109 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $512,449 | 3,800 | Put | Sole | 2026-02-13 | |
| 2025-03-31 | $1,380,281 | 220,845 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,215,339 | 302,642 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,965,443 | 257,417 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,334,784 | 176,610 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,674,729 | 187,044 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||